Intrexon Corporation
(NASDAQ : XON)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.53%200.551.2%$532.14m
GILDGilead Sciences, Inc.
3.35%75.220.9%$475.19m
BIIBBiogen Inc.
1.72%334.051.3%$391.26m
CELGCelgene Corporation
2.05%83.511.2%$346.15m
ILMNIllumina, Inc.
1.59%318.393.5%$302.38m
REGNRegeneron Pharmaceuticals, Inc.
4.57%394.822.6%$238.94m
ALXNAlexion Pharmaceuticals, Inc.
4.56%127.032.0%$224.89m
VRTXVertex Pharmaceuticals Incorporated
3.00%182.971.9%$216.79m
SRPTSarepta Therapeutics, Inc.
5.49%138.5516.4%$180.51m
AAgilent Technologies, Inc.
2.16%67.051.5%$160.89m
BMRNBioMarin Pharmaceutical Inc.
4.21%103.644.4%$141.07m
LGNDLigand Pharmaceuticals Incorporated
6.06%212.1923.3%$122.35m
VKTXViking Therapeutics, Inc.
6.97%15.190.9%$119.84m
NKTRNektar Therapeutics
3.06%50.585.6%$112.39m
EXASExact Sciences Corporation
1.25%66.6025.3%$104.32m

Company Profile

Intrexon Corp. is a biotechnology company, which engages in the business of synthetic biology. It focuses on on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The firm offers UltraVector, RheoSwitch, cell systems informatics, protein engineering, and antibody discovery. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.